Crossmark Global Holdings, Inc. Repligen Corp Transaction History

Crossmark Global Holdings, Inc.

$6.02 Billion
Q2 2025

A detailed history of Crossmark Global Holdings, Inc. transactions in Repligen Corp stock. As of the latest transaction made, Crossmark Global Holdings, Inc. holds 3,932 shares of RGEN stock, worth $607,690. This represents 0.01% of its overall portfolio holdings.

Number of Shares

3,932

Previous 4,108 4.28%

Holding current value

$607,690

Previous $522,000 6.32%

% of portfolio

0.01%

Previous 0.01%

33 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 08, 2025	SELL	$108.89 - $145.23 $19,164 - $25,560	-176 Reduced 4.28%	3,932 $489,000
Q1 2025 Apr 29, 2025	BUY	$127.24 - $174.24 $21,249 - $29,098	167 Added 4.24%	4,108 $522,000
Q4 2024 Jan 16, 2025	SELL	$123.41 - $160.92 $15,673 - $20,436	-127 Reduced 3.12%	3,941 $567,000
Q3 2024 Nov 04, 2024	BUY	$119.79 - $167.35 $52,228 - $72,964	436 Added 12.0%	4,068 $606,000
Q2 2024 Jul 29, 2024	SELL	$120.0 - $182.95 $52,440 - $79,949	-437 Reduced 10.74%	3,632 $458,000
Q1 2024 May 13, 2024	BUY	$170.78 - $208.42 $45,085 - $55,022	264 Added 6.94%	4,069 $748,000
Q4 2023 Feb 13, 2024	SELL	$114.17 - $185.35 $36,420 - $59,126	-319 Reduced 7.74%	3,805 $684,000
Q3 2023 Nov 08, 2023	SELL	$138.78 - $176.51 $14,433 - $18,357	-104 Reduced 2.46%	4,124 $640,000
Q2 2023 Jul 31, 2023	SELL	$138.42 - $180.31 $48,031 - $62,567	-347 Reduced 7.58%	4,228 $737,000
Q1 2023 May 12, 2023	BUY	$154.26 - $198.1 $27,921 - $35,856	181 Added 4.12%	4,575 $770,000
Q4 2022 Jan 19, 2023	BUY	$162.42 - $220.56 $6,009 - $8,160	37 Added 0.85%	4,394 $744,000
Q3 2022 Nov 01, 2022	BUY	$160.42 - $256.21 $1,122 - $1,793	7 Added 0.16%	4,357 $815,000
Q2 2022 Jul 29, 2022	SELL	$140.68 - $188.02 $5,627 - $7,520	-40 Reduced 0.91%	4,350 $707,000
Q1 2022 May 11, 2022	SELL	$161.19 - $257.96 $53,192 - $85,126	-330 Reduced 6.99%	4,390 $826,000
Q4 2021 Jan 10, 2022	SELL	$247.59 - $304.47 $584,312 - $718,549	-2,360 Reduced 33.33%	4,720 $1.25 Million
Q3 2021 Oct 21, 2021	BUY	$194.77 - $324.21 $1.38 Million - $2.3 Million	7,080 New	7,080 $2.05 Million
Q3 2021 Oct 13, 2021	SELL	$194.77 - $324.21 $1.45 Million - $2.42 Million	-7,460 Closed	0 $0
Q2 2021 Jul 21, 2021	SELL	$165.87 - $220.95 $58,054 - $77,332	-350 Reduced 4.48%	7,460 $1.49 Million
Q1 2021 Apr 15, 2021	BUY	$180.37 - $226.26 $1,803 - $2,262	10 Added 0.13%	7,810 $1.52 Million
Q4 2020 Jan 14, 2021	BUY	$148.08 - $206.57 $65,155 - $90,890	440 Added 5.98%	7,800 $1.5 Million
Q3 2020 Oct 08, 2020	BUY	$122.51 - $158.27 $9,800 - $12,661	80 Added 1.1%	7,360 $1.09 Million
Q2 2020 Aug 14, 2020	BUY	$94.33 - $140.48 $80,180 - $119,407	850 Added 13.22%	7,280 $900,000
Q1 2020 Apr 28, 2020	SELL	$84.96 - $109.14 $3,398 - $4,365	-40 Reduced 0.62%	6,430 $620,000
Q4 2019 Feb 06, 2020	BUY	$73.84 - $93.08 $13,291 - $16,754	180 Added 2.86%	6,470 $598,000
Q3 2019 Oct 09, 2019	SELL	$76.65 - $95.51 $766 - $955	-10 Reduced 0.16%	6,290 $482,000
Q2 2019 Jul 09, 2019	SELL	$54.2 - $85.95 $9,756 - $15,471	-180 Reduced 2.78%	6,300 $541,000
Q1 2019 May 02, 2019	SELL	$49.45 - $62.8 $4,450 - $5,652	-90 Reduced 1.37%	6,480 $383,000
Q4 2018 Jan 31, 2019	SELL	$48.26 - $68.88 $188,696 - $269,320	-3,910 Reduced 37.31%	6,570 $347,000
Q3 2018 Nov 08, 2018	BUY	$46.8 - $58.97 $15,911 - $20,049	340 Added 3.35%	10,480 $581,000
Q2 2018 Jul 31, 2018	BUY	$35.26 - $47.04 $14,456 - $19,286	410 Added 4.21%	10,140 $477,000
Q1 2018 Apr 16, 2018	SELL	$30.92 - $37.27 $23,499 - $28,325	-760 Reduced 7.24%	9,730 $352,000
Q4 2017 Feb 05, 2018	BUY	$32.53 - $38.92 $136,300 - $163,074	4,190 Added 66.51%	10,490 $381,000
Q3 2016 Oct 25, 2017	BUY	N/A	6,300	6,300 $241,000

Others Institutions Holding RGEN

# of Institutions

506

Shares Held

58.9M

Call Options Held

89.3K

Put Options Held

679K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.58B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Crossmark Global Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Crossmark Global Holdings, Inc. with notifications on news.

Account

Crossmark Global Holdings, Inc. Repligen Corp Transaction History